Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | # Peptides (by Search Engine): A2 Sequest HT (IgG) | # Peptides (by Search Engine): B2 Sequest HT (Sel1L) | # Peptides (by Search Engine): C2 Sequest HT (WT) | # Peptides (by Search Engine): D2 Sequest HT (HKO) | # PSMs (by Search Engine): A2 Sequest HT (IgG) | # PSMs (by Search Engine): B2 Sequest HT (Sel1L) | # PSMs (by Search Engine): C2 Sequest HT (WT) | # PSMs (by Search Engine): D2 Sequest HT (HKO) | Abundance: F1: Sample, IgG | Abundance: F2: Sample, Sel1L | Abundance: F3: Sample, WT | Abundance: F4: Sample, HKO | Abundances Count: F1: Sample, IgG | Abundances Count: F2: Sample, Sel1L | Abundances Count: F3: Sample, WT | Abundances Count: F4: Sample, HKO | Modifications | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Ensembl Gene ID | Gene Symbol | Chromosome | Reactome Pathways | KEGG Pathways | # Razor Peptides |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medium | Q9Y5B9 | FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1 | 0.033 | 1.305 | 1 | 1 | 1 | 1 | 1047 | 119.8 | 5.66 | 1 | 1 | 466876.8125 | 232601.375 | 192575.6875 | 1 | 1 | 1 | Met-loss+Acetyl [N-Term] | cell organization and biogenesis;metabolic process;regulation of biological process;response to stimulus | chromosome;nucleus | protein binding;RNA binding | "Pf00557, Pf08512, Pf08644, Pf14826" | 11198 | ENSG00000092201.9 | SUPT16H | 14 | HIV elongation arrest and recovery; TP53 Regulates Transcription of DNA Repair Genes; Tat-mediated HIV elongation arrest and recovery; Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Pre-transcription Events; Pausing and recovery of HIV elongation; Pausing and recovery of Tat-mediated HIV elongation; Formation of HIV-1 elongation complex containing HIV-1 Tat | 0 |